- These new Alzheimer’s drugs could transform treatment The i Paper —
- Newsletter Exclusive: How to reduce your brain's biological age in just three months, by a world-leading neurologist whose regime is clinically proven to work. Use our interactive brain calculator - and follow the guide Daily Mail —
- Dementia drugs hailed as 'beginning of the end' for Alzheimer's do not work, major report finds Daily Mail —
- Alzheimer's drugs make 'no meaningful difference' RTE —
- 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests BBC News —
- The surprising value of boring chats, ‘super El Niño’ and Alzheimer’s evidence reviewed – podcast The Guardian —
- Alzheimer’s drugs targeting amyloid don’t help, review finds The Japan Times —
- Much-hyped Alzheimer’s drugs do not help patients, review finds The Straits Times —
- Alzheimer’s drugs ‘make no meaningful difference to patients,’ major review suggests The Independent —
- Effect of ‘gamechanger’ Alzheimer’s drugs ‘trivial’, review concludes The Guardian —
Alzheimer's Drugs Benefits Questioned
The review of 17 clinical trials involving anti-amyloid drugs found that while the medicines successfully remove plaques from the brain, they fail to significantly slow cognitive decline.
Researchers described the clinical benefits as 'trivial' and highlighted the serious risks of brain swelling and bleeding associated with the treatments.
Some dementia experts have criticized the analysis, arguing that it unfairly groups failed experimental drugs with recently approved breakthroughs.
The report's conclusions could have profound implications for how healthcare systems like the NHS prioritize funding for expensive new Alzheimer's therapies.